Avreo and Annalise.ai Partner to Transform Radiology Triage
The companies join forces to transform the US radiology landscape with a focus on teleradiology
North Charleston, SC – November 29, 2023. Today, Avreo, a leading US healthcare workflow solution provider, announced an exciting partnership with Annalise.ai, a pioneer in artificial intelligence for medical imaging. This collaboration aims to revolutionize radiology triage for US healthcare centers through the distribution of Annalise.ai's cutting-edge solution with a focus on teleradiology providers.
Avreo's innovative interWORKS platform offers cloud-based access to workflow management, diagnostic viewing, and unified reporting tools that excel in distributed reading environments and seamlessly interoperate with enterprise healthcare systems.
Annalise triage is set to transform the radiology field by empowering radiologists to efficiently prioritize studies with suspected critical findings. This innovative solution streamlines workflow, supporting faster time-to-detect for urgent conditions."By embedding Annalise.ai's powerful technology directly into the interWORKS worklist and diagnostic viewer, radiology groups can strategically manage imaging workflows with elevated confidence, improve rapid response reporting on critical exams, and deliver higher quality services to their clients and patients," said Timothy Rose, VP Business Development at Avreo Inc.
Annalise Triage features an impressive selection of 12 FDA-cleared findings, encompassing 5 for chest X-ray (CXR) and 7 for non-contrast brain CT (CTB). This comprehensive offering has obtained the 510(k) clearances and also the FDA breakthrough designation for obstructive hydrocephalus. Annalise Triage stands as the sole radiology triage device to attain this recognition, exclusively awarded to devices meeting specific criteria*.
"The integration of Annalise Triage with Avreo’s suite of digital products enables streamlined diagnostic workflows for radiologists and will help guide providers to the most appropriate action at the ideal time to deliver the best possible patient care", added Timothy.
"We are thrilled to join forces with Avreo to bring our triage solution to a wider audience," said Lakshmi Gudapakkam, CEO at Annalise.ai. "The synergy between our AI-driven capabilities and Avreo's industry-leading workflow solutions will undoubtedly make a positive impact on radiologists' day-to-day operations."
By incorporating Annalise.ai's triage solution into Avreo's comprehensive suite of healthcare workflow tools, radiologists can expect improved triaging and increased efficiency in managing high-priority cases. The collaboration aligns with both companies1 shared commitment to advancing patient care through innovative technologies.
For more information on the partnership, visit https://www.avreo.com and https://annalise.ai/.
*FDA website as of March 2023
1 Breakthrough Devices Program | FDA These criteria include: enhancing the diagnosis or treatment of life-threatening or irreversibly debilitating conditions; introducing breakthrough technology; providing a significant advantage over existing alternatives; and prioritizing the well-being of patients Annalise Triage is only available in the U.S. The device is intended for use by healthcare professionals only. The device is not intended to provide diagnosis. For detailed device information, including indications for use, contraindications, and warnings, please consult the user guide prior to use.
About Avreo Inc.
Founded in 1997 and based in North Charleston, SC, Avreo is a leading healthcare software provider of the only single database complete PACS/RIS/EHR solution, cohesively connecting each step in the radiology workflow and improving the overall structure for healthcare organizations across the country. With a series of awards and recognitions from top industry researchers such as KLAS and Frost & Sullivan, Avreo is driven to improve the overall structure for healthcare organizations across the country. Avreo’s product line continues to focus on healthcare workflow solutions with the addition of Avreo Cloud VR, Avreo Cloud Archive, and other related healthcare digital products.
About Annalise.ai
Annalise.ai is a global health-tech firm that has touched the lives of millions across the globe. Our patient-first approach is proudly clinician-led and comes from a deep understanding of the challenges faced in medical imaging. Our AI provides clinicians with a second set of eyes, allowing them to review radiological studies with confidence and deliver better health outcomes for patients. With accelerating advances in medical imaging technology, radiologists and other Health Care providers are now expected to diagnose patients quickly and accurately. Annalise.ai fuses the highest quality imaging data with the very best in computer science to produce comprehensive AI clinical decision support solutions, empowering clinicians to make accurate decisions, faster. Today Annalise.ai is cleared to be used in 40+ countries. In the US, it has the most comprehensive triage solution for Chest X-rays and non-contrast Head CTs, with FDA breakthrough designation for obstructive hydrocephalus.